PURE Bioscience (OTCMKTS:PURE) Stock Crosses Above 200 Day Moving Average – Here’s Why

Shares of PURE Bioscience (OTCMKTS:PURE) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0822. PURE Bioscience shares last traded at $0.0785, with a volume of 123,796 shares.

PURE Bioscience Stock Up 20.8%

The stock has a market capitalization of $8.78 million, a PE ratio of -2.62 and a beta of 0.52. The firm’s fifty day moving average price is $0.05 and its two-hundred day moving average price is $0.06.

PURE Bioscience Company Profile

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.